This study investigates an artificial intelligence-based tool for matching cancer patients to clinical trials. The focus is on patients with advanced solid and hematological cancers.
The study evaluates the tool's effectiveness in improving clinical trial enrollment and examines its impact on patient outcomes, such as progression-free survival and overall survival.
- Who can participate: Adults and children with advanced solid or blood cancers can participate. Key eligibility factors include specific cancer-related biomarkers and a decision by the primary provider to consider clinical trial enrollment.
- Study details: Participants will have their clinical data analyzed by an AI tool to match them with suitable clinical trials. The study is non-interventional, meaning no specific tests or procedures are required.
- Study timelines: The study will last 36 months.
How understandable was the trial content above?
Hard to understand
Easy to understand